Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger B Cohen

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
Frontiers in Oncology|May 8, 2026
Carboplatin plus pemetrexed versus pemetrexed alone in advanced thymoma and thymic carcinoma: a retrospective cohort studyBenjamin A Bleiberg, Lauren Reed-Guy, Roger B Cohen, et al.
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancerHossein Borghaei, Katherine Alpaugh, Gunnar Hedlund, et al.
Clinical Lung Cancer|November 14, 2017
Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II StudyCharu Aggarwal, Roger B Cohen, Eddy Yu, et al.
Head & Neck|August 21, 2009
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiationMiriam N Lango, Brian Egleston, Kevin Ende, et al.
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2015
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignanciesMargaret von Mehren, Michael Bookman, Neal J Meropol, et al.
Journal of Cancer Survivorship : Research and Practice|September 6, 2018
Barriers to physical activity: a study of academic and community cancer survivors with painSally A D Romero, Justin C Brown, Joshua M Bauml, et al.
Oncotarget|October 17, 2015
Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapyAnna K Brady, Jonathan D McNeill, Brendan Judy, et al.
Translational Lung Cancer Research|July 10, 2023
Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patientsJu-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Frontiers in Oncology|May 8, 2026
Carboplatin plus pemetrexed versus pemetrexed alone in advanced thymoma and thymic carcinoma: a retrospective cohort studyBenjamin A Bleiberg, Lauren Reed-Guy, Roger B Cohen, et al.
Cancer|May 20, 2016
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinomaJared M Weiss, Stephen Bagley, Wei-Ting Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancerHossein Borghaei, Katherine Alpaugh, Gunnar Hedlund, et al.
Clinical Lung Cancer|November 14, 2017
Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II StudyCharu Aggarwal, Roger B Cohen, Eddy Yu, et al.
Head & Neck|August 21, 2009
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiationMiriam N Lango, Brian Egleston, Kevin Ende, et al.
JAMA Oncology|June 4, 2023
Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung CancerLova Sun, Benjamin Bleiberg, Wei-Ting Hwang, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2015
Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignanciesMargaret von Mehren, Michael Bookman, Neal J Meropol, et al.
Journal of Cancer Survivorship : Research and Practice|September 6, 2018
Barriers to physical activity: a study of academic and community cancer survivors with painSally A D Romero, Justin C Brown, Joshua M Bauml, et al.
Oncotarget|October 17, 2015
Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapyAnna K Brady, Jonathan D McNeill, Brendan Judy, et al.
Translational Lung Cancer Research|July 10, 2023
Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patientsJu-Yoon Yoon, Jacquelyn J Roth, Chase A Rushton, et al.
Pageof 21